Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


GASTROINTESTINAL TOXICITY side effect

What is GASTROINTESTINAL TOXICITY ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   GASTROINTESTINAL TOXICITY and Recently Reported Side Effects   GASTROINTESTINAL TOXICITY and 15 most Active Side Effect polls   GASTROINTESTINAL TOXICITY and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with GASTROINTESTINAL TOXICITY

BEVACIZUMAB  CAPECITABINE  CARBOPLATIN  EPIRUBICIN  ERLOTINIB  FLUOROURACIL  GEMZAR  HERCEPTIN  IFOSFAMIDE  INTRON  IRINOTECAN  LAPATINIB  LAPATINIBLET  MABTHERA  REVLIMID  THALOMID  VELCADE  


Lapatiniblet Side Effects Report #5646136-9
Physician from FRANCE reported LAPATINIBLET problem on Feb 15, 2008. Female patient, 70 years of age, was diagnosed with breast cancer metastatic and was treated with LAPATINIBLET. After drug was administered, patient experienced the following problems/side effects: gastrointestinal toxicity, . LAPATINIBLET dosage: unknown. Patient recovered.

Velcade Side Effects Report #5615521-3
VELCADE problem was reported by a Physician from SPAIN on Jan 22, 2008. Female patient, child 1 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal toxicity, . VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Revlimid Side Effects Report #5640597-7
Physician from UNITED STATES reported REVLIMID problem on Nov 07, 2007. Female patient, 67 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: gastrointestinal toxicity, . REVLIMID dosage: 25 MG, DAILY X 21 DAYS, ORAL. Patient recovered.

Ifosfamide Side Effects Report #5452647-1
IFOSFAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient was diagnosed with squamous cell carcinoma and was treated with IFOSFAMIDE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal toxicity, haematotoxicity, . IFOSFAMIDE dosage: FIXED DOSES OF IFOSFAMIDE (1200MG/M2) WITH MESNA WAS ADMINISTERED ON DAYS 1 TO 4.. During the same period patient was treated with CISPLATIN, MESNA, DOCETAXEL, CAPECITABINE. Patient recovered.


Intron Side Effects Report #5258995-2
Physician from UNITED STATES reported INTRON A problem on Feb 27, 2007. Female patient, 45 years of age, was diagnosed with malignant melanoma and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: gastrointestinal toxicity, . INTRON A dosage: unknown. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5652118-3
ERLOTINIB problem was reported by a Physician from SPAIN on Feb 25, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal toxicity, . ERLOTINIB dosage: 100 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDE, EPOETIN BETA, NEUPOGEN, BUPERORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.

Irinotecan Side Effects Report #5622531-9
Consumer or non-health professional from reported IRINOTECAN problem on Feb 04, 2008. Male patient, 69 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: acidosis, gastrointestinal toxicity, neutropenia, pneumatosis intestinalis, portal venous gas, . IRINOTECAN dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5633040-5
VELCADE problem was reported by a Physician from ITALY on Feb 04, 2008. Female patient, 59 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, gastrointestinal toxicity, leukocytoclastic vasculitis, multiple myeloma, nausea, stem cell transplant, therapeutic response decreased, tumour lysis syndrome, vasculitis gastrointestinal, . VELCADE dosage: 1.30 MG/M2; 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Epirubicin Side Effects Report #5642167-3
Consumer or non-health professional from ITALY reported EPIRUBICIN problem on Feb 15, 2008. Female patient, 35 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: asthenia, gastrointestinal toxicity, nausea, vomiting, . EPIRUBICIN dosage: 145 MG IV. During the same period patient was treated with ENDOXAN. Patient was hospitalized. Patient recovered.


Carboplatin Side Effects Report #5610650-2
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 15, 2008. Female patient, 71 years of age, was diagnosed with ovarian epithelial cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: asthenia, gastrointestinal toxicity, hypotension, intestinal perforation, multi-organ failure, neutropenia, post procedural complication, post procedural sepsis, tachycardia, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5572368-4
Physician from SPAIN reported VELCADE problem on Dec 12, 2007. Female patient, 46 years of age, was diagnosed with primary amyloidosis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: autonomic nervous system imbalance, gastrointestinal toxicity, hepatomegaly, muscle atrophy, neuropathy, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Herceptin Side Effects Report #5575443-3
HERCEPTIN problem was reported by a Physician from UNITED KINGDOM on Nov 20, 2007. Female patient, 58 years of age, was diagnosed with breast cancer metastatic and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: cardiotoxicity, gastrointestinal toxicity, . HERCEPTIN dosage: 220 MG, UNK. During the same period patient was treated with VINORELBINE, TAXOTERE, PACLITAXEL, CARBOPLATIN. Patient recovered.

Capecitabine Side Effects Report #5525299-X
Health Professional from FRANCE reported CAPECITABINE problem on Nov 13, 2007. Female patient was diagnosed with prophylaxis of nausea and vomiting and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: electrolyte imbalance, gastrointestinal toxicity, infection, thrombocytopenia, vision blurred, . CAPECITABINE dosage: unknown. During the same period patient was treated with IROFULVEN, ANTIEMETIC. Patient recovered.

Capecitabine Side Effects Report #5476850-X
CAPECITABINE problem was reported by a Health Professional from ITALY on Sept 24, 2007. Male patient was diagnosed with prophylaxis of nausea and vomiting and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal toxicity, neutropenia, thrombocytopenia, vomiting, . CAPECITABINE dosage: unknown. During the same period patient was treated with EPIRUBICIN, CISPLATIN, ANTIEMETIC, DEXAMETHASONE. Patient died.


Bevacizumab Side Effects Report #5398257-6
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on July 11, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastritis, gastrointestinal toxicity, pancytopenia, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5398257-6
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on July 11, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastritis, gastrointestinal toxicity, pancytopenia, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Thalomid Side Effects Report #5742310-1
Health Professional from FRANCE reported THALOMID problem on May 06, 2008. Male patient, 58 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: disease recurrence, gastrointestinal toxicity, multiple myeloma, neurotoxicity, paraplegia, spinal disorder, . THALOMID dosage: 200 MG, PER DAY, ORAL. Patient recovered.

Capecitabine Side Effects Report #5694931-2
CAPECITABINE problem was reported by a Health Professional from ITALY on Mar 24, 2008. Male patient was diagnosed with prophylaxis of nausea and vomiting and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal toxicity, neutropenia, thrombocytopenia, vomiting, . CAPECITABINE dosage: unknown. During the same period patient was treated with EPIRUBICIN, CISPLATIN, ANTIEMETIC, DEXAMETHASONE. Patient died.

Lapatinib Side Effects Report #5342182-3
Physician from SPAIN reported LAPATINIB problem on May 24, 2007. Female patient, 47 years of age, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal toxicity, rectal haemorrhage, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.


Lapatinib Side Effects Report #5369526-0
LAPATINIB problem was reported by a Physician from SPAIN on June 15, 2007. Female patient, 47 years of age, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal toxicity, rectal haemorrhage, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5263900-9
Physician from ITALY reported GEMZAR problem on Feb 26, 2007. Female patient, 74 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: asthenia, gastrointestinal toxicity, neutropenia, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient recovered.

Mabthera Side Effects Report #5269659-3
MABTHERA problem was reported by a Health Professional from IRELAND on Mar 02, 2007. Male patient, 59 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, gastrointestinal toxicity, haemoglobin decreased, hyperkalaemia, pco2 decreased, renal tubular acidosis, . MABTHERA dosage: unknown. During the same period patient was treated with CYTARABINE, CARMUSTINE, ETOPOSIDE, MELPHALAN, ZOFRAN, ALLOPURINOL, SEPTRA. Patient recovered.

Fluorouracil Side Effects Report #5535728-3
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Dec 04, 2007. Male patient, weighting 170.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anaemia, enterococcal infection, gastrointestinal toxicity, hiatus hernia, oesophageal dilatation, oesophageal stenosis, renal failure, skin toxicity, urinary retention, . FLUOROURACIL dosage: unknown. During the same period patient was treated with XELODA, CAMPTOSAR, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Lapatinib Side Effects Report #5554295-1
LAPATINIB problem was reported by a Physician from SPAIN on Dec 12, 2007. Female patient, 45 years of age, was diagnosed with breast cancer and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic, eating disorder, gastrointestinal toxicity, hepatotoxicity, hyperbilirubinaemia, ileus paralytic, mucosal inflammation, multi-organ failure, neutropenia, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA. Patient was hospitalized. Patient died on 07/08/2007.

Carboplatin Side Effects Report #5510849-X
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Oct 23, 2007. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, colitis ischaemic, gastrointestinal toxicity, . CARBOPLATIN dosage: 150 MG FREQ UNK. During the same period patient was treated with ONXOL. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about GASTROINTESTINAL TOXICITY side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about GASTROINTESTINAL TOXICITY